Furthermore, patients with cirrhosis and HCC had higher levels of both AAT and kininogen than those with cirrhosis alone, and combining kininogen and AAT with AFP and Golgi protein 73 resulted in an increased sensitivity of 95%, a specificity of 70%, and AUROC of 0.94 for the detection of HCC [185]. This evidence concerns the gene AFP and hepatocellular carcinoma.